• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负重与非负重全接触石膏治疗活动期夏科氏足:一项系统评价。

Weight bearing versus non-weight bearing total contact cast in the management of active Charcot foot: A systematic review.

作者信息

Prem Rachna, Vignaraja Vikramman, Lewis Thomas, Budair Basil

机构信息

Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

King's Foot and Ankle Unit, King's College Hospital NHS Foundation Trust, London, UK.

出版信息

SAGE Open Med. 2024 Dec 16;12:20503121241306957. doi: 10.1177/20503121241306957. eCollection 2024.

DOI:10.1177/20503121241306957
PMID:39691864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11650502/
Abstract

AIM

Diabetic Charcot neuro-osteoarthropathy carries a significant worldwide disease burden including diabetic foot infection, ulceration and amputation. The current accepted standard of treatment during the active phase of Charcot neuro-osteoarthropathy is offloading with total contact casting; however, controversy remains regarding weight-bearing status during this period.

METHODS

A systematic review was performed following PRISMA guidelines of Pubmed, EMBASE, MEDLINE and the Cochrane central register of controlled trials for clinical studies from inception until June 2024 investigating weight-bearing and non-weight-bearing total contact casting for active Charcot neuro-osteoarthropathy.

RESULTS

Four hundred ninety-three studies were identified in the search strategy of which 5 studies met the inclusion criteria comprising 158 patients. These studies found that allowing patients to weight-bear during total contact casting does not have a negative impact on the healing process. There were no comparative studies between weight-bearing and non-weight-bearing total contact casting.

CONCLUSIONS

There is limited evidence to support current practice of non-weight bearing in a total contact casting for active Charcot neuro-osteoarthropathy. Allowing patients to weight bear carries advantages to patient independence and quality of life. Further investigation with randomised control trial should be considered to investigate if weight bearing is associated with negative outcomes.

摘要

目的

糖尿病夏科氏神经骨关节病在全球范围内造成了重大疾病负担,包括糖尿病足感染、溃疡和截肢。目前公认的夏科氏神经骨关节病活动期治疗标准是采用全接触石膏进行减压;然而,在此期间的负重状态仍存在争议。

方法

按照PRISMA指南,对PubMed、EMBASE、MEDLINE以及Cochrane对照试验中心注册库进行系统综述,纳入自研究起始至2024年6月期间调查活动期夏科氏神经骨关节病负重和非负重全接触石膏治疗的临床研究。

结果

在检索策略中识别出493项研究,其中5项研究符合纳入标准,共纳入158例患者。这些研究发现,在全接触石膏治疗期间允许患者负重对愈合过程没有负面影响。负重和非负重全接触石膏治疗之间没有比较研究。

结论

支持目前对活动期夏科氏神经骨关节病采用非负重全接触石膏治疗的证据有限。允许患者负重对患者的独立性和生活质量有好处。应考虑通过随机对照试验进行进一步研究,以调查负重是否与不良结局相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/edf87b0de6b3/10.1177_20503121241306957-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/8410936afa56/10.1177_20503121241306957-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/45eae3349818/10.1177_20503121241306957-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/edf87b0de6b3/10.1177_20503121241306957-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/8410936afa56/10.1177_20503121241306957-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/45eae3349818/10.1177_20503121241306957-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/11650502/edf87b0de6b3/10.1177_20503121241306957-fig3.jpg

相似文献

1
Weight bearing versus non-weight bearing total contact cast in the management of active Charcot foot: A systematic review.负重与非负重全接触石膏治疗活动期夏科氏足:一项系统评价。
SAGE Open Med. 2024 Dec 16;12:20503121241306957. doi: 10.1177/20503121241306957. eCollection 2024.
2
Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review.糖尿病患者伴骨髓炎的中足夏科氏神经关节病的手术治疗:系统评价。
J Wound Care. 2020 Jun 1;29(Sup6):S19-S28. doi: 10.12968/jowc.2020.29.Sup6.S19.
3
Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review.糖尿病患者活动性夏科特神经关节病的诊断与治疗:一项系统评价
Diabetes Metab Res Rev. 2024 Mar;40(3):e3653. doi: 10.1002/dmrr.3653. Epub 2023 May 14.
4
Fibreglass Total Contact Casting, Removable Cast Walkers, and Irremovable Cast Walkers to Treat Diabetic Neuropathic Foot Ulcers: A Health Technology Assessment.玻璃纤维全接触石膏固定、可拆卸石膏步行靴及不可拆卸石膏步行靴治疗糖尿病神经性足溃疡:一项卫生技术评估
Ont Health Technol Assess Ser. 2017 Sep 21;17(12):1-124. eCollection 2017.
5
The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy.Syme截肢术对糖尿病足综合征和夏科氏神经骨关节病患者手术治疗的影响。
Arch Orthop Trauma Surg. 2004 Apr;124(3):145-50. doi: 10.1007/s00402-003-0622-9. Epub 2004 Feb 10.
6
Offloading Interventions for the Management of Charcot Neuroarthropathy in Diabetes.糖尿病性夏科氏神经关节病管理中的减负干预措施
Foot Ankle Orthop. 2025 Feb 10;10(1):24730114251315670. doi: 10.1177/24730114251315670. eCollection 2025 Jan.
7
Circular External Fixation as a New Offloading Standard of Treatment in Charcot Neuro-Osteoarthropathy Complicated by Midfoot Osteomyelitis: A Pilot, Prospective Case-Control Study.环形外固定作为合并中足骨髓炎的夏科氏神经骨关节病的一种新的减负治疗标准:一项前瞻性试点病例对照研究
Int J Low Extrem Wounds. 2025 Mar;24(1):170-176. doi: 10.1177/15347346231185403. Epub 2023 Jul 11.
8
The effectiveness of non-surgical interventions in the treatment of Charcot foot.非手术干预在治疗夏科氏足中的疗效。
Int J Evid Based Healthc. 2007 Dec;5(4):437-49. doi: 10.1111/j.1479-6988.2007.00081.x.
9
The effectiveness of non-surgical interventions in the treatment of Charcot foot.
JBI Libr Syst Rev. 2007;5(10):558-576. doi: 10.11124/01938924-200705100-00001.
10
[Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients].[糖尿病患者夏科氏足神经关节病重建的中期结果]
Acta Chir Orthop Traumatol Cech. 2019;86(1):51-57.

引用本文的文献

1
Charcot foot disease: A new approach.夏科氏足病:一种新方法。
Drugs Aging. 2025 Aug 11. doi: 10.1007/s40266-025-01234-0.
2
Management of hindfoot and ankle in Charcot arthropathy.夏科氏关节病中后足和踝关节的管理
EFORT Open Rev. 2025 Jun 2;10(6):327-335. doi: 10.1530/EOR-2025-0057.

本文引用的文献

1
Early versus delayed weight-bearing following operatively treated ankle fracture (WAX): a non-inferiority, multicentre, randomised controlled trial.手术治疗踝关节骨折后早期与延迟负重(WAX):一项非劣效性、多中心、随机对照试验。
Lancet. 2024 Jun 29;403(10446):2787-2797. doi: 10.1016/S0140-6736(24)00710-4. Epub 2024 Jun 4.
2
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.糖尿病性神经关节病:是时候改变我们的思维模式了。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3754. doi: 10.1002/dmrr.3754. Epub 2023 Dec 8.
3
Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023).
《糖尿病相关活跃性夏科氏骨-神经病的诊断和治疗指南(IWGDF 2023)》。
Diabetes Metab Res Rev. 2024 Mar;40(3):e3646. doi: 10.1002/dmrr.3646. Epub 2023 May 23.
4
Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study.总接触式石膏固定治疗急性夏科氏足的时间:一项回顾性队列研究。
J Foot Ankle Res. 2021 Jun 15;14(1):44. doi: 10.1186/s13047-021-00477-5.
5
Optimal care for the management of older people non-weight bearing after lower limb fracture: a consensus study.老年人下肢骨折后非负重管理的最佳护理:一项共识研究。
BMC Geriatr. 2021 May 24;21(1):332. doi: 10.1186/s12877-021-02265-z.
6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
7
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.2020年RSSDI-ESI 2型糖尿病管理临床实践建议
Indian J Endocrinol Metab. 2020 Jan-Feb;24(1):1-122. doi: 10.4103/ijem.IJEM_225_20.
8
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.系统评价中不进行荟萃分析的综合 (SWiM):报告指南。
BMJ. 2020 Jan 16;368:l6890. doi: 10.1136/bmj.l6890.
9
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
10
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.ROBINS-I:一种评估干预性非随机研究偏倚风险的工具。
BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919.